Genetic and Environmental Risk Factors Related to Esophageal Cancer (NCT01035398) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Genetic and Environmental Risk Factors Related to Esophageal Cancer
United StatesStarted 2000-04
Plain-language summary
RATIONALE: Gathering information about genes, cigarette smoking, and diet may help doctors learn more about risk factors that may cause esophageal cancer.
PURPOSE: This clinical trial is studying genetic and environmental risk factors related to esophageal cancer.
Who can participate
Age range
18 Years – 100 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
DISEASE CHARACTERISTICS:
* Meets 1 of the following criteria:
* Diagnosis of esophageal cancer (patient)
* Newly diagnosed disease
* Receiving care at Massachusetts General Hospital, Thoracic Oncology Center
* Friend or spouse of patient (healthy participants)
PATIENT CHARACTERISTICS:
* No concurrent psychiatric incapacity or dementia
PRIOR CONCURRENT THERAPY:
* Not specified
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Polymorphisms in various pathways, DNA repair, free-radical formation, inflammatory genes, metastatic potential, and cell cycle or tumor suppression in blood samples
Timeframe: 2000-2016
2
Comparison of presence or absence of variant polymorphisms between cases and controls
Timeframe: 2000-2016
3
Correlation between polymorphisms in blood samples and polymorphisms in tissue specimens
Timeframe: 2000-2016
4
Analyses of dietary factors and Helicobacter pylori infection (previous vs current)